Dublin, March 10, 2025 (GLOBE NEWSWIRE) -- The "Gold Sodium Thiosulfate (CAS 10233-88-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been ...

The analysts forecast the global sodium thiosulfate market to exhibit a CAGR of 2.89% during the period 2019-2024.The report covers the present scenario and the growth prospects of the global sodium ...

Investigators performed a meta-analysis of intravenous sodium thiosulfate studies involving patients with calciphylaxis and chronic kidney disease.

The global sodium thiosulfate market is projected to grow at a CAGR of 2.89% during the period from 2019 to 2024. This comprehensive report covers the current scenario and future prospects of the ...

The clinical trial evidence for anhydrous sodium thiosulfate is from 2 phase 3, open-label, randomised controlled trials comparing cisplatin-based chemotherapy plus anhydrous sodium thiosulfate with ...

As randomized controlled studies on sodium thiosulfate are lacking, this Perspectives article focuses on case reports and case series; in these reports the compound seemed to be effective and was ...

This makes sodium thiosulfate the first and only FDA-approved treatment for this indication and patient population.

Simultaneous biological oxidation of sodium thiosulfate and organic carbon was studied in continuous bench-scale activated sludge reactors. Thiosulfate oxidation did not influence organic carbon ...

Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature The following represents disclosure information provided by authors of ...

~ Positive CHMP Opinion Based on Clinical Results Demonstrating Prevention of Ototoxicity and a Favorable Benefit-Risk Profile With Pedmarqsi~ ...

PURPOSEHearing loss occurs in 50%-70% of children treated with cisplatin. Scientific efforts have led to the recent approval of a pediatric formula of intravenous sodium thiosulfate (STS) for ...